Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol
November 2004
Researchers are excited about Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol.
The lay press has picked up on this too-good-to-be-true drug, and people are asking about it.
It's the first in a new class...called selective cannabinoid type 1 (CB1) blockers.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive